"I think a lot of folks here at NIH are experiencing just moral distress about the things we're being asked to do," Dr. Jenna ...

Regional teams across the country have been instructed, at times, to limit sharing information with their state and local ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

The Senate voted to advance President Donald Trump's One Big Beautiful Bill (H.R. 1) on Tuesday, approving nearly $1 trillion ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

"Regulatory T cells (Treg cells) play a crucial role in maintaining immune homeostasis. As such, Immuthera’s and PolTREG’s delivery of Tregs offers hope for curing or controlling autoimmune diseases, ...

Cancer fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell ...

Overview of the MarketThe global AI in Oncology For Analytical Solutions Market is valued at USD 1.09 billion in 2024 and is ...

Early recovery from drug addiction to opioids and stimulants is physically and mentally demanding, and a long road to recovery."During the early ...

Leaders at the Doylestown-based organizations said sweeping spending cuts across multiple federal agencies threaten not only ...

Canceled grants and slashed budgets are disproportionately affecting junior health researchers, dealing a major blow to the ...

Drastic cuts to NIH will halt brain research on the cusp of transformational treatments. These setbacks could derail future cures in ways that we may not be able to recover from for decades.